glp-1 substance abuse GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and intake, though What to know about how

Journal of the American Heart Association, 15, e047893

The answer, experts say, has less to do with the medications themselves and more to do with what happens when appetite and consumption of certain foods fall dramatically

Throughout her 25+ year career, Ashley Koff RD has helped hundreds of patients, practitioners and thousands of audience members achieve lasting weight health powered by truly personalized nutrition

This obstruction manifests the symptoms of CAD such as substernal discomfort and a pressure-like feeling, which may radiate to the jaw, shoulder, back, or arm

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1 Trial)